Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2010

Apr 15, 2010

32870_dirs_2010-04-15_949cce24-8175-404e-812a-3b26a1fcb99c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2010-04-13

Reporting Person: Elsey R Don (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-04-13 Common Stock M 5000 $3.50 Acquired 5300 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-04-13 Employee Stock Option (right to buy) $3.50 M 5000 Disposed 2010-06-06 Common Stock (5000) Direct

Footnotes

F1: The option is fully vested.